The volume of announced deals involving UK targets in the first two quarters of the year fell 68.6% compared to the same period last year, leading to the quietest start to a calendar year for dealmaking since 2009.
Watch Mergermarket’s Virtual Event on the M&A market outlook in the CEE region here.
Jonathan Klonowski
Research Editor EMEA, Mergermarket
European M&A looks set to remain at historically low levels through 2020 with a recovery unlikely until mid-2021, as the world continues to grapple with the coronavirus pandemic and its economic consequences.
Watch Mergermarket’s Virtual Event on the Nordic market outlook and the impact of Covid-19 here.
US asset and wealth management M&A saw a significant uptick before the coronavirus pandemic, fueled in part by aging registered investment advisors looking to sell at high valuations amid a booming stock market. While current volatility has put the brakes on activity, some deals are still getting done and the longer term prospects look healthy, notably driven by strong interest from private equity. Raymond James’ Liz and Peter Nesvold recently joined host Tom Cane to discuss the unfolding landscape for the sector. It's a time for companies to learn good habits in bad times and position themselves for future opportunities. According to Mergermarket data, Raymond James has been one of the most active investment banks in the field, with recent deals including advising Stratos Wealth Holdings on a strategic minority investment from Emigrant Partners.
The German economy is set to shrink by 10% in the three months to June as a result of the COVID-19 pandemic, but the DACH region is yet to see the effect of the pandemic on M&A value following several large transactions announced prior to the outbreak.
The CEE region saw a healthy level of dealmaking prior to the outbreak of coronavirus, but saw a fall in March as M&A across Europe began to slow. The region saw a clear decline by value, although fared better than other parts of Europe, while the deal count fell to its lowest point in several years.
Thorsten Louie Pedersen
Research Analyst, Mergermarket
As uncertainty surrounding the coronavirus pandemic began to hit corporates, the Nordic region fell short in attracting sizable deals in 1Q20 but instead witnessed a growing focus on start-ups and medium enterprises, a trend that is likely to continue.
Global dealmaking has been brought to a standstill in the past few weeks and activity is likely to remain subdued for the coming months, according the Mergermarket's Q1 global M&A trend report.
Bill Curtin, Hogan Lovell’s global head of mergers and acquisitions, recently joined Mergermarket managing editor Tom Cane to discuss the impact of COVID-19 on M&A activity both in the immediate future and on the longer term horizon. What are companies and advisors doing now to get through this unprecedented challenge? Where will opportunities emerge and who is best placed to capitalize on them?
Pablo Mayo Cerqueiro
Financial Services Correspondent, Acuris
European financial services companies experienced lower levels of M&A in 2019 versus the year before both in terms of transaction volume and value, according to Mergermarket data. However, industry dealmakers are tipped to remain busy, as insurers and banks review their operations while bourses and private equity investors scout for deals.
The Pharma, Medical and Biotech (PMB) sector has seen a significant rise in the value of deals in 2019, despite a slowdown in M&A activity
Deane McRobie
Senior Reporter, Mergermarket
Consumer sector M&A activity in 2019 fared better in Europe than in the rest of the world
No more items to load
Load moreAn error occurred trying to play the stream. Please reload the page and try again.
Close
